Filing Details
- Accession Number:
- 0001835830-24-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-17 16:40:20
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-17 16:40:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1835830 | Klaviyo Inc. | KVYO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1673606 | Susan Ledger St. | C/O Klaviyo, Inc. 125 Summer Street, 6Th Floor Boston MA 02110 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Series A Common Stock | Acquisiton | 2024-05-16 | 10,500 | $0.00 | 10,500 | No | 4 | C | Direct | |
Series A Common Stock | Disposition | 2024-05-16 | 10,500 | $24.66 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Series A Common Stock | Series B Common Stock | Disposition | 2024-05-15 | 10,500 | $0.00 | 10,500 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
59,500 | No | 4 | C | Direct |
Footnotes
- Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
- Consists of (i) 12,833 shares of Series B Common Stock and (ii) 46,667 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.